SCHEMBL17048972

SCHEMBL17048972

COc1cccc(O)c1C(=O)CN(Cc1cc(F)cc(F)c1)C(=O)c1cnn(C2CCC(C(=O)O)CC2)c1C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LPAR1 Q92633 4/20 0.34
LPAR5 Q9H1C0 4/20 0.34
TAS2R14 Q9NYV8 1/20 0.33
LTC4S Q16873 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
EGFR P00533 1/20 0.32
BTK Q06187 1/20 0.32
CCR3 P51677 1/20 0.31
TNF P01375 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4D Q08499 1/20 0.31
LITAF Q99732 1/20 0.31
HCRTR2 O43614 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17048970 1.00 ALDH1A1 (0.34) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17097660 0.96 LPAR1 (0.35) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17048992 0.96 LPAR1 (0.35) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17098144 0.93 ALDH1A1 (0.35) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17098141 0.93 ALDH1A1 (0.35) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17098547 0.93 MEN1 (0.32) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL17098960 0.93 MEN1 (0.32) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL17097627 0.92 EGFR (0.34) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17097625 0.92 EGFR (0.34) ALDH1A1KDM4ELMNAMAPTHTT
SCHEMBL17098673 0.90 RORC (0.33) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US claimed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US claimed
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
EP-3110810-A1 PYRAZOLE AMIDE DERIVATIVE Teijin Pharma Limited (JP) 2017-01-04 EP disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
WO-2015129926-A1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LIMITED (JP) 2015-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA ALDH1A1 923/4885KDM4E 986/4885LMNA 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.